Skip to Main Content

Paper Details

Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia.
Cancer Discov
13
2022
AML, AML cells, Acute Myeloid Leukemia, HTR1B, IDO1, Kynurenine, Osteoblasts, SAA, Serotonin, Serotonin Receptor, acute myeloid leukemia, cancer, kynurenine, leukemia, leukemia cells, leukemia-, mouse, osteoblast, osteoblasts, patient, patient-derived xenografts, resistant clones, serotonin, serotonin receptor 1B, serum amyloid A, tumor, tumor cells
Author NameAffiliation
Xi-Ping HuangUniversity of North Carolina Chapel Hill Medical School
Brygida BisikirskaColumbia University
Bryan L RothUniversity of North Carolina Chapel Hill Medical School
Bryan L RothEshelman School of Pharmacy, University of North Carolina at Chapel Hill
Bryan L RothUniversity of North Carolina Chapel Hill Medical School
Bryan L RothEshelman School of Pharmacy, University of North Carolina at Chapel Hill
Raul RabadanColumbia University
Raul RabadanColumbia University
  • 1 - 8

Datasets

Release 1.2